• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酮 IIA 可减轻感染牙龈卟啉单胞菌的载脂蛋白 E 基因敲除小鼠的动脉粥样硬化。

Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.

机构信息

Department of Periodontology, Peking University School and Hospital of Stomatology, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, 22 Zhongguancun Avenue South, Haidian District, Beijing, 100081, China.

Central Laboratory, Peking University School and Hospital of Stomatology, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, 22 Zhongguancun Avenue South, Haidian District, Beijing, 100081, China.

出版信息

Inflammation. 2017 Oct;40(5):1631-1642. doi: 10.1007/s10753-017-0603-8.

DOI:10.1007/s10753-017-0603-8
PMID:28646427
Abstract

Tanshinone IIA (TSA), a pharmacologically active component isolated from Danshen, may prevent cardiovascular diseases due to its anti-inflammatory, anti-oxidative, and anti-adipogenic effects. Porphyromonas gingivalis, a major periodontal pathogen, may contribute to the progression of atherosclerosis. Here, we studied the effects of TSA on atherosclerosis in ApoE mice with P. gingivalis infection. Eight-week-old ApoE mice were randomized to (a) phosphate-buffered saline (PBS), (b) P. gingivalis, and (c) P. gingivalis + TSA (60 mg kg day). The mice were injected with (a) PBS, or (b) and (c) P. gingivalis 3 times per week for a total of 10 times. After 8 weeks, atherosclerotic risk factors in serum and in heart, aorta, and liver tissues were analyzed in all mice using Oil Red O, atherosclerosis cytokine antibody arrays, enzyme-linked immunosorbent assay (ELISA), real-time PCR, and microRNA array. CD40, G-CSF, IFN-γ, interleukin (IL)-1β, IL-6, MCP-1, MIP-3α, tumor necrosis factor-α (TNF-α), and VEGF were attenuated by TSA in atherosclerosis cytokine antibody arrays. TSA-treated mice showed a significant reduction of C-reactive protein (CRP), ox-LDL, IL-1β, IL-6, IL-12, and TNF-α in ELISA data. Real-time PCR analyses showed that TSA decreased the expression of CCL-2, CD40, IL-1β, IL-6, TNF-α, and MMP-2 in heart and aorta tissues. Moreover, hepatic CRP was downregulated by TSA, although FASN and HMG-CoA were not. The relative expressions of miR-146b and miR-155 were elevated by P. gingivalis infection and were downregulated by TSA treatment. These results suggest that TSA was a potential therapeutic agent that may have the ability to prevent P. gingivalis-induced atherosclerosis associated with anti-inflammatory and anti-oxidative effects.

摘要

丹参酮 IIA(TSA)是从丹参中分离得到的一种具有药理活性的成分,由于其具有抗炎、抗氧化和抗脂肪生成作用,可能预防心血管疾病。牙龈卟啉单胞菌是一种主要的牙周病原体,可能导致动脉粥样硬化的进展。在这里,我们研究了 TSA 对感染牙龈卟啉单胞菌的 ApoE 小鼠动脉粥样硬化的影响。将 8 周龄的 ApoE 小鼠随机分为(a)磷酸盐缓冲液(PBS),(b)牙龈卟啉单胞菌和(c)牙龈卟啉单胞菌+ TSA(60mgkg 天)。每周向小鼠注射(a)PBS,或(b)和(c)牙龈卟啉单胞菌 3 次,共 10 次。8 周后,用油红 O、动脉粥样硬化细胞因子抗体阵列、酶联免疫吸附试验(ELISA)、实时 PCR 和 microRNA 阵列分析所有小鼠血清和心脏、主动脉和肝脏组织中的动脉粥样硬化危险因素。在动脉粥样硬化细胞因子抗体阵列中,TSA 减弱了 CD40、G-CSF、IFN-γ、白细胞介素(IL)-1β、IL-6、MCP-1、MIP-3α、肿瘤坏死因子-α(TNF-α)和 VEGF。TSA 处理的小鼠在 ELISA 数据中显示 C 反应蛋白(CRP)、氧化低密度脂蛋白(ox-LDL)、IL-1β、IL-6、IL-12 和 TNF-α显著减少。实时 PCR 分析表明,TSA 降低了心脏和主动脉组织中 CCL-2、CD40、IL-1β、IL-6、TNF-α和 MMP-2 的表达。此外,尽管 FASN 和 HMG-CoA 没有,TSA 也下调了肝 CRP。牙龈卟啉单胞菌感染上调了 miR-146b 和 miR-155 的相对表达,而 TSA 处理则下调了其表达。这些结果表明,TSA 可能是一种潜在的治疗药物,具有通过抗炎和抗氧化作用预防牙龈卟啉单胞菌诱导的动脉粥样硬化的能力。

相似文献

1
Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.丹参酮 IIA 可减轻感染牙龈卟啉单胞菌的载脂蛋白 E 基因敲除小鼠的动脉粥样硬化。
Inflammation. 2017 Oct;40(5):1631-1642. doi: 10.1007/s10753-017-0603-8.
2
[Effect of infection on atherosclerosis in apolipoprotein-E knockout mice].[感染对载脂蛋白E基因敲除小鼠动脉粥样硬化的影响]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):743-749. doi: 10.19723/j.issn.1671-167X.2020.04.028.
3
Protective effects of tanshinone IIA on Porphyromonas gingivalis-induced atherosclerosis via the downregulation of the NOX2/NOX4-ROS mediation of NF-κB signaling pathway.丹参酮IIA通过下调NOX2/NOX4-ROS介导的NF-κB信号通路对牙龈卟啉单胞菌诱导的动脉粥样硬化具有保护作用。
Microbes Infect. 2023 Nov-Dec;25(8):105177. doi: 10.1016/j.micinf.2023.105177. Epub 2023 Jun 29.
4
Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.罗格列酮通过下调动脉粥样硬化小鼠的TLR/NF-κB信号通路来抑制牙龈卟啉单胞菌加速的动脉粥样硬化。
Int Immunopharmacol. 2014 Dec;23(2):701-8. doi: 10.1016/j.intimp.2014.10.026.
5
Porphyromonas gingivalis Infection Accelerates Atherosclerosis Mediated by Oxidative Stress and Inflammatory Responses in ApoE-/- Mice.牙龈卟啉单胞菌感染加速载脂蛋白E基因敲除小鼠中由氧化应激和炎症反应介导的动脉粥样硬化
Clin Lab. 2017 Oct 1;63(10):1627-1637. doi: 10.7754/Clin.Lab.2017.170410.
6
Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.人β-防御素-3减轻牙龈卟啉单胞菌脂多糖加速的动脉粥样硬化进程。
Int Immunopharmacol. 2016 Sep;38:204-13. doi: 10.1016/j.intimp.2016.06.003. Epub 2016 Jun 10.
7
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.绿茶表没食子儿茶素-3-没食子酸酯减轻牙龈卟啉单胞菌诱导的动脉粥样硬化。
Pathog Dis. 2013 Feb;67(1):76-83. doi: 10.1111/2049-632X.12001. Epub 2012 Nov 15.
8
Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis.牙龈卟啉单胞菌感染增强Th17反应,促进动脉粥样硬化的发展。
Arch Oral Biol. 2014 Nov;59(11):1183-91. doi: 10.1016/j.archoralbio.2014.07.012. Epub 2014 Jul 24.
9
Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.白细胞介素-1受体信号传导在小鼠载脂蛋白E杂合子模型中介导与细菌暴露和/或高脂饮食相关的动脉粥样硬化:药物治疗意义。
Circulation. 2004 Sep 21;110(12):1678-85. doi: 10.1161/01.CIR.0000142085.39015.31. Epub 2004 Sep 7.
10
Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.丹参酮 II-A 可减轻并稳定高胆固醇饮食喂养的载脂蛋白 E 基因敲除小鼠的动脉粥样硬化斑块。
Arch Biochem Biophys. 2011 Nov;515(1-2):72-9. doi: 10.1016/j.abb.2011.08.006. Epub 2011 Aug 26.

引用本文的文献

1
Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases.利用丹参酮IIA的治疗价值:心血管疾病的突破性疗法。
Front Pharmacol. 2025 Jul 4;16:1620152. doi: 10.3389/fphar.2025.1620152. eCollection 2025.
2
Examining the Relationship Between Obesity and Income Distribution Using Body Mass Index (BMI) and Body Shape and Size Index (BSSI): A Case Study of Pakistan.使用体重指数(BMI)和身体形状与尺寸指数(BSSI)研究肥胖与收入分配之间的关系:以巴基斯坦为例
Gerontol Geriatr Med. 2024 Oct 5;10:23337214241288795. doi: 10.1177/23337214241288795. eCollection 2024 Jan-Dec.
3

本文引用的文献

1
Functional regulatory roles of microRNAs in atherosclerosis.microRNAs 在动脉粥样硬化中的功能调节作用。
Clin Chim Acta. 2016 Sep 1;460:164-71. doi: 10.1016/j.cca.2016.06.044. Epub 2016 Jul 3.
2
The GroEL protein of Porphyromonas gingivalis regulates atherogenic phenomena in endothelial cells mediated by upregulating toll-like receptor 4 expression.牙龈卟啉单胞菌的GroEL蛋白通过上调Toll样受体4的表达来调节内皮细胞中的动脉粥样硬化相关现象。
Am J Transl Res. 2016 Feb 15;8(2):384-404. eCollection 2016.
3
Porphyromonas gingivalis Differentially Modulates Cell Death Profile in Ox-LDL and TNF-α Pre-Treated Endothelial Cells.
Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review.
揭示丹参酮作为心血管疾病新斗士的保护作用机制:系统评价。
Cardiovasc Toxicol. 2024 Dec;24(12):1467-1509. doi: 10.1007/s12012-024-09921-x. Epub 2024 Sep 22.
4
Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects.丹参山楂方治疗动脉粥样硬化:民族药理学相关性、制备方法、化学成分、药代动力学特性及药理作用
Front Pharmacol. 2024 Jun 7;15:1380977. doi: 10.3389/fphar.2024.1380977. eCollection 2024.
5
Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis.丹参酮IIA:一种用于治疗动脉粥样硬化的中药成分。
Front Pharmacol. 2023 Dec 1;14:1321880. doi: 10.3389/fphar.2023.1321880. eCollection 2023.
6
Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease.用于治疗代谢相关脂肪性肝病的靶向免疫细胞的中药和天然产物。
Front Pharmacol. 2023 Jun 9;14:1195146. doi: 10.3389/fphar.2023.1195146. eCollection 2023.
7
An overview of natural products that modulate the expression of non-coding RNAs involved in oxidative stress and inflammation-associated disorders.调节参与氧化应激和炎症相关疾病的非编码RNA表达的天然产物概述。
Front Pharmacol. 2023 Apr 24;14:1144836. doi: 10.3389/fphar.2023.1144836. eCollection 2023.
8
Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway.牙龈卟啉单胞菌菌血症通过 Mfsd2a/Caveolin-1 介导的胞吞转运途径增加血脑屏障的通透性。
Int J Oral Sci. 2023 Jan 12;15(1):3. doi: 10.1038/s41368-022-00215-y.
9
Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.非小鼠动脉粥样硬化模型:探索新疗法转化潜力的方法。
Int J Mol Sci. 2022 Oct 26;23(21):12964. doi: 10.3390/ijms232112964.
10
Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis.基于谱效关系和网络药理学分析的血栓心脉宁片活血成分鉴定
RSC Adv. 2020 Mar 10;10(16):9587-9600. doi: 10.1039/c9ra09623j. eCollection 2020 Mar 2.
牙龈卟啉单胞菌对氧化型低密度脂蛋白和肿瘤坏死因子-α预处理的内皮细胞的细胞死亡模式有不同调节作用。
PLoS One. 2016 Apr 28;11(4):e0154590. doi: 10.1371/journal.pone.0154590. eCollection 2016.
4
miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.微小RNA-155通过抑制钙调节热稳定蛋白1,在动脉粥样硬化相关泡沫细胞形成中发挥抗炎因子的作用。
Sci Rep. 2016 Feb 22;6:21789. doi: 10.1038/srep21789.
5
Tanshinone IIA affects the HDL subfractions distribution not serum lipid levels: Involving in intake and efflux of cholesterol.丹参酮IIA影响高密度脂蛋白亚组分分布而非血清脂质水平:涉及胆固醇的摄取和流出。
Arch Biochem Biophys. 2016 Feb 15;592:50-9. doi: 10.1016/j.abb.2016.01.001. Epub 2016 Jan 26.
6
Periodontitis and osteoporosis.牙周炎与骨质疏松症。
Neuro Endocrinol Lett. 2015;36(5):401-6.
7
Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE null Mice.四种牙周细菌引起的多微生物口腔感染在载脂蛋白E基因敲除小鼠中引发独特的炎症反应和动脉粥样硬化。
PLoS One. 2015 Nov 30;10(11):e0143291. doi: 10.1371/journal.pone.0143291. eCollection 2015.
8
Effects of Intravenous Injection of Porphyromonas gingivalis on Rabbit Inflammatory Immune Response and Atherosclerosis.静脉注射牙龈卟啉单胞菌对兔炎症免疫反应和动脉粥样硬化的影响
Mediators Inflamm. 2015;2015:364391. doi: 10.1155/2015/364391. Epub 2015 May 3.
9
Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis.丹参酮 IIA 抗动脉粥样硬化的抗炎及免疫调节机制。
Evid Based Complement Alternat Med. 2014;2014:267976. doi: 10.1155/2014/267976. Epub 2014 Dec 2.
10
Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.罗格列酮通过下调动脉粥样硬化小鼠的TLR/NF-κB信号通路来抑制牙龈卟啉单胞菌加速的动脉粥样硬化。
Int Immunopharmacol. 2014 Dec;23(2):701-8. doi: 10.1016/j.intimp.2014.10.026.